| Name | Title | Contact Details |
|---|
Crouse Hospital has been caring for generations of Central New Yorkers since 1887. Our mission is to provide the best in patient care by exceeding the expectations of our patients and to promote community health. A private, not-for-profit hospital, Crouse is licensed for 506 acute-care beds and 57 bassinets. We serve more than 23,000 inpatients, 66,000 emergency services patients and more than 250,000 outpatients a year from a 15-county area in Central and Northern New York.
PetDx® – The Liquid Biopsy Company for Pets™ is a molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health.
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
Medwise Partners is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GroupOne Healthsource is a Jefferson City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.